• Don’t Waste A Pandemic: Patient Advocates Call For Continuing Growth Toward Patient Centricity

    Clinical Research News | The COVID-19 pandemic has forced clinical trial sponsors and sites to think outside the box, offering innovative services to help patient recruitment, sample collection, and other phases of clinical research. There’s also another voice that needs to be considered: namely, that of the patient.

    Aug 31, 2020
  • Hydroxychloroquine, Remdesivir, Rehab: COVID-19 Updates

    Clinical Research News | Recommendations for COVID-19 rehabilitation, four months of data from Italy’s use of hydroxychloroquine, more data on which comorbidities are most dangerous, Remdesivir data, and more on imaging. Plus, research grants and a convalescent plasma architecture.

    Aug 28, 2020
  • Pack Health Deploying Digital Coaches For At-Home Disease Management

    Clinical Research News| The pandemic has deepened the disconnect with healthcare providers for patients with chronic conditions by reducing the frequency of in-person encounters while heightening patients’ anxiety about how to self-manage and access trusted health advice when they need it. Pack Health specializes in digital health coaching for just such scenarios.

    Aug 26, 2020
  • Caris, Thermo Fisher Scientific, And More: News From August 2020

    Clinical Research News | August was full of exciting news in the clinical trial and healthcare community, including partnerships, products, and promotions from Caris, Thermo Fisher Scientific, and more.

    Aug 24, 2020
  • Ethnic Disparities, Variations in Antibody Response, Transmission-Humidity Link: COVID-19 Updates

    Clinical Research News | More evidence for disparities in the prevalence of COVID-19 across racial/ethnic subgroups, different types of detectable antibody responses tell different stories, potential cause for the loss of smell, and a transmission-humidity link. Plus, vaccine trials in South Africa, and launch of phage-based vaccines.

    Aug 21, 2020
  • FDA Releases Civil Money Penalties Procedures For Not Posting Clinical Trials, Results

    Clinical Research News| The Food and Drug Administration released its nonbinding recommendations for civil money penalties relating to the data submitted to ClinicalTrials.gov earlier this week. They outlined how they plan to identify parties that have failed to submit required clinical trial registration or results information, what the investigation and notification process will be, and what civil money penalties may be assessed and when.

    Aug 19, 2020